Joincare Ebitda from 2010 to 2024
| 600380 Stock | 11.12 0.05 0.45% |
EBITDA | First Reported 2010-12-31 | Previous Quarter 4 B | Current Value 3.1 B | Quarterly Volatility 1.7 B |
Check Joincare Pharmaceutical financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Joincare Pharmaceutical's main balance sheet or income statement drivers, such as Interest Expense of 154.1 M, Selling General Administrative of 2.7 B or Total Revenue of 17.5 B, as well as many indicators such as . Joincare financial statements analysis is a perfect complement when working with Joincare Pharmaceutical Valuation or Volatility modules.
Joincare | Ebitda |
Currently Active Assets on Macroaxis
Other Information on Investing in Joincare Stock
Joincare Pharmaceutical financial ratios help investors to determine whether Joincare Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Joincare with respect to the benefits of owning Joincare Pharmaceutical security.